Cleared Traditional

K903426 - INSULIN SYRINGE GUIDE

K903426 is an FDA 510(k) clearance for INSULIN SYRINGE GUIDE, manufactured by Bay State Anesthesia, Inc.. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 57-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1990
Decision
57d
Days
Class 2
Risk

K903426 is an FDA 510(k) clearance for the INSULIN SYRINGE GUIDE. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Bay State Anesthesia, Inc. (North Andover, US). The FDA issued a Cleared decision on September 26, 1990 after a review of 57 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bay State Anesthesia, Inc. devices

FDA 510(k) Submission Details - K903426

510(k) Number K903426 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 31, 1990
Decision Date September 26, 1990
Days to Decision 57 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
72d faster than avg
Panel avg: 129d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 539
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K903426.
DAVOL IMPLANT PORTS W/ATTACH HI PERF GROSHONG CATH
K913235 · Davol, Inc. · Oct 1991
B-D(TM) MICROFINE(TM) IV PEN INJECTOR CAT. #328204
K912330 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Oct 1991
JOHNSON & JOHNSON DUAL SYRINGE APPLICATOR
K902157 · Johnson & Johnson Medical, Inc. · Nov 1990
DISPOSABLE CORONARY CONTROL SYRINGE
K902346 · Advance Medical Designs, Inc. · Jun 1990
AUTOPEN
K895890 · Ulster Scientific, Inc. · Feb 1990
INTOPO
K894206 · Acacia, Inc. · Oct 1989